ACER THERAPEUTICS INC - COM (ACER) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2017 to Q1 2024

Type / Class
Equity / COM
Symbol
ACER
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ACER THERAPEUTICS INC - COM (ACER) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$1,000 0
2023 Q4 1,000 $1,000 -$3,399,574 $1.00 1
2023 Q3 4,166,029 $3,400,574 +$1,287,220 $0.82 28
2023 Q2 2,508,985 $2,316,771 -$1,548,385 $0.92 25
2023 Q1 4,591,780 $3,484,682 +$1,289,687 $0.76 24
2022 Q4 2,447,655 $6,139,998 +$2,199,558 $2.51 30
2022 Q3 1,598,210 $2,219,249 +$62,237 $1.39 23
2022 Q2 1,554,516 $1,957,226 +$166,657 $1.26 21
2022 Q1 1,419,369 $4,117,519 -$126,663 $2.90 15
2021 Q4 1,469,088 $3,350,412 -$159,512 $2.28 16
2021 Q3 1,526,543 $3,909,456 -$111,033 $2.56 20
2021 Q2 1,563,581 $4,472,512 -$306,830 $2.86 25
2021 Q1 1,654,276 $5,144,557 -$2,149,681 $3.11 23
2020 Q4 2,500,940 $6,550,469 +$841,137 $2.62 23
2020 Q3 1,919,358 $5,529,516 -$253,984 $2.88 17
2020 Q2 2,001,448 $6,862,746 -$914,554 $3.43 27
2020 Q1 2,295,690 $4,585,086 -$516,087 $1.99 33
2019 Q4 2,425,546 $9,723,807 -$760,898 $4.01 36
2019 Q3 2,612,110 $8,328,791 +$402,476 $3.19 35
2019 Q2 2,465,128 $9,596,051 -$36,855,400 $3.90 34
2019 Q1 3,137,156 $76,222,000 +$3,451,976 $24.30 33
2018 Q4 3,029,395 $60,926,000 -$994,956 $20.12 27
2018 Q3 2,993,507 $92,316,000 +$71,146,651 $30.84 28
2018 Q2 721,394 $15,581,000 +$2,513,541 $21.60 15
2018 Q1 611,769 $11,776,000 +$2,449,388 $19.26 15
2017 Q4 554,615 $7,696,000 +$7,690,000 $13.85 12
2017 Q3 398 $8,000 +$8,000 $26.18 2